{"protocolSection":{"identificationModule":{"nctId":"NCT06475846","orgStudyIdInfo":{"id":"HRS5580-201"},"organization":{"fullName":"Fujian Shengdi Pharmaceutical Co., Ltd.","class":"INDUSTRY"},"briefTitle":"A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults","officialTitle":"A Evaluate HRS5580 for Injection for Prevention of Postoperative Nausea and Vomiting Efficacy and Safety of Ⅱ Period, Randomized, Multicenter, Dose of Exploration, Positive Control, Placebo-controlled, Double-blind, Double Simulation Trials"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-06","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2024-10","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-11","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-13","studyFirstSubmitQcDate":"2024-06-19","studyFirstPostDateStruct":{"date":"2024-06-26","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-19","lastUpdatePostDateStruct":{"date":"2024-06-26","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Fujian Shengdi Pharmaceutical Co., Ltd.","class":"INDUSTRY"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The study is being conducted to evaluate the efficacy, and safety of HRS5580 for preventing of postoperative nausea and vomiting in adults. To explore the reasonable dosage of HRS5580 for postoperative nausea and vomiting."},"conditionsModule":{"conditions":["Preventing of Postoperative Nausea and Vomiting in Adults"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":232,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Treatment group A: HRS5580","type":"EXPERIMENTAL","interventionNames":["Drug: HRS5580"]},{"label":"Treatment group B: HRS5580","type":"EXPERIMENTAL","interventionNames":["Drug: HRS5580"]},{"label":"Treatment group C: HRS5580","type":"EXPERIMENTAL","interventionNames":["Drug: HRS5580"]},{"label":"Treatment group D: Ondansetron","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ondansetron"]},{"label":"Treatment group E: blank preparation.","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: blank preparation"]}],"interventions":[{"type":"DRUG","name":"HRS5580","description":"HRS5580; low dose","armGroupLabels":["Treatment group A: HRS5580"]},{"type":"DRUG","name":"HRS5580","description":"HRS5580; middle dose","armGroupLabels":["Treatment group B: HRS5580"]},{"type":"DRUG","name":"HRS5580","description":"HRS5580; middle dose","armGroupLabels":["Treatment group C: HRS5580"]},{"type":"DRUG","name":"Ondansetron","description":"Ondansetron","armGroupLabels":["Treatment group D: Ondansetron"]},{"type":"DRUG","name":"blank preparation","description":"blank preparation.","armGroupLabels":["Treatment group E: blank preparation."]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"No vomiting rate within 72 hours after extubation","timeFrame":"at 72 hours after extubation"}],"secondaryOutcomes":[{"measure":"Complete response rate (defined as the proportion of subjects without vomiting and receiving no rescue therapy) at 24, 48, 72, 96, and 120 hours after extubation","timeFrame":"at24, 48, 72, 96, and 120 hours after extubation"},{"measure":"No vomiting at 24, 48, 96, and 120 hours after extubation,","timeFrame":"at 24, 48, 96, and 120 hours after extubation"},{"measure":"Proportion of subjects who did not experience significant nausea within 24, 48, 72, 96, and 120 hours after extubation","timeFrame":"at 24, 48, 72, 96, and 120 hours after extubation"},{"measure":"Proportion of participants not receiving rescue medication within 24, 48, 72, 96, and 120 hours of extubation","timeFrame":"at 24, 48, 72, 96, and 120 hours of extubation"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Able and willing to provide a written informed consent\n2. Plan to undergo elective surgery under general anesthesia；\n3. ≥18 years old\n4. Meet the weight standard\n5. Conform to the ASA Physical Status Classification\n6. Expected postoperative hospital stay ≥72 hours\n7. PONV risk factors ≥3\n\nExclusion Criteria:\n\n1. Subjects with vomiting and/or retching and nausea occurred before surgery\n2. Subjects with a history of vestibular disease, central nervous system and other system diseases\n3. Subjects with a previous history of chronic nausea or vomiting/retching\n4. Subjects with a history of myocardial infarction or unstable angina pectoris\n5. Subjects with atrioventricular block or cardiac insufficiency\n6. Subjects with a history of ischemic stroke or transient ischemic attack\n7. Subjects with poor blood pressure control after medication\n8. Abnormal electrocardiogram\n9. Abnormal values in the laboratory\n10. Allergic to a drug ingredient or component\n11. Received treatment with potential antiemetic effects before starting the investigational product\n12. Subjects who received chemotherapy prior to surgery\n13. Use of drugs that affect the antiemetic effect, and the time between the last use of the test drug and the start of the time is less than 5 half-lives\n14. Plan to receive local anesthesia only or total intravenous anesthesia only\n15. Subjects who are expected to require an in-situ nasogastric tube or orogastric tube after completion of surgery\n16. Subjects expected to be transferred to the ICU at the end of surgery\n17. Pregnant or nursing women\n18. No birth control during the specified period of time\n19. Participated in clinical trials of other drugs (received experimental drugs)\n20. The inestigators determined that other conditions were inappropriate for participation in this clinical trial","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Qin Liu","role":"CONTACT","phone":"+0518-82342973","email":"qin.liu@hengrui.com"}],"locations":[{"facility":"Beijing Friendship Hospital, Capital Medical University","city":"Beijing","state":"Beijing","zip":"100050","country":"China","contacts":[{"name":"Zhongtao Zhang","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":39.9075,"lon":116.39723}},{"facility":"Third Xiangya Hospital of Central South University","city":"Changsha","state":"Hunan","zip":"410013","country":"China","contacts":[{"name":"Wen Ouyang","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":28.19874,"lon":112.97087}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000009325","term":"Nausea"},{"id":"D000014839","term":"Vomiting"},{"id":"D000020250","term":"Postoperative Nausea and Vomiting"}],"ancestors":[{"id":"D000012817","term":"Signs and Symptoms, Digestive"},{"id":"D000011183","term":"Postoperative Complications"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M12273","name":"Nausea","asFound":"Nausea","relevance":"HIGH"},{"id":"M17582","name":"Vomiting","asFound":"Vomiting","relevance":"HIGH"},{"id":"M22074","name":"Postoperative Nausea and Vomiting","asFound":"Postoperative Nausea and Vomiting","relevance":"HIGH"},{"id":"M15622","name":"Signs and Symptoms, Digestive","relevance":"LOW"},{"id":"M14065","name":"Postoperative Complications","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"All","name":"All Conditions"}]},"interventionBrowseModule":{"meshes":[{"id":"D000017294","term":"Ondansetron"}],"ancestors":[{"id":"D000000932","term":"Antiemetics"},{"id":"D000001337","term":"Autonomic Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000005765","term":"Gastrointestinal Agents"},{"id":"D000000982","term":"Antipruritics"},{"id":"D000003879","term":"Dermatologic Agents"},{"id":"D000058831","term":"Serotonin 5-HT3 Receptor Antagonists"},{"id":"D000012702","term":"Serotonin Antagonists"},{"id":"D000018490","term":"Serotonin Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M19588","name":"Ondansetron","asFound":"Natural","relevance":"HIGH"},{"id":"M4251","name":"Antiemetics","relevance":"LOW"},{"id":"M8881","name":"Gastrointestinal Agents","relevance":"LOW"},{"id":"M7074","name":"Dermatologic Agents","relevance":"LOW"},{"id":"M15512","name":"Serotonin","relevance":"LOW"},{"id":"M29246","name":"Serotonin 5-HT3 Receptor Antagonists","relevance":"LOW"},{"id":"M20504","name":"Neurotransmitter Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnEm","name":"Antiemetics"},{"abbrev":"Derm","name":"Dermatologic Agents"},{"abbrev":"Gast","name":"Gastrointestinal Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}